SIMI FIRM SUES FDA IN TEST CASE OVER DIET SUPPLEMENT.Byline: Mike Carter Associated Press Associated Press: see news agency. Associated Press (AP) Cooperative news agency, the oldest and largest in the U.S. and long the largest in the world. The Simi Valley-based maker of the dietary supplement Noun 1. dietary supplement - something added to complete a diet or to make up for a dietary deficiency diet - a prescribed selection of foods vitamin pill - a pill containing one or more vitamins; taken as a dietary supplement Cholestin claims it promotes healthy cholesterol, which it very well might do because it contains traces of a chemical that doctors prescribe to lower people's cholesterol. But the presence of that naturally occurring chemical, known as mevinolin, in red yeast powder a baling powder, - used instead of yeast in leavening bread. See also: Yeast from China has prompted the Food and Drug Administration to ban importation of the substance. In a case that could define the FDA's ability to regulate over-the-counter diet supplements, a federal judge said Monday that he would rule as early as today on whether to order the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ban lifted. Pharmanex, which markets the yeast powder under the name Cholestin, has asked U.S. District Judge Dale Kimball to stop the FDA from interfering with the company's imports. ``This represents a total failure of the FDA to obey Congress and the law,'' said Richard Cooper Richard Cooper may refer to:
Cooper said Pharmanex is within five days of exhausting its supply of red yeast rice red yeast rice, n See monascus. powder and would be irreparably harmed if the judge doesn't order the FDA to back off. Mevinolin is identical to a synthetically produced cholesterol-reducing drug, lovastatin lovastatin /lo·va·stat·in/ (lo´vah-stat?in) an antihyperlipidemic agent that acts by inhibiting cholesterol synthesis, used in the treatment of hypercholesterolemia and other forms of dyslipidemia and to lower the risks associated with . The pharmaceutical giant Merck & Co. sells lovastatin under the brand name Mevacor. The dispute is the first challenge to the FDA's powers under the 1994 Dietary Supplement Health and Education Act. The law provided for the widespread sale of herbs, teas and capsules containing ingredients that are not FDA-approved as safe and effective. But it also set two major restrictions. First, any FDA-approved drug ingredients cannot also be sold as dietary supplements unless they were sold as a supplement or a food before the drug was approved. Second, supplement manufacturers may claim only general benefits for the ingredient, rather than cures, preventions or treatments of diseases. FDA regulators say Cholestin - which is sold in 35,000 stores nationwide - runs afoul of the law on both counts: It was not sold as a supplement before Mevacor was approved, and Pharmanex has made improper claims about its effectiveness. Pharmanex lawyer Dan Kracov contends the FDA is trying to use the 1994 law to smother distribution of the yeast. |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion